Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

10HY

Structure of CHK1 10-pt. mutant complex with macrocyclic LRRK2 inhibitor compound 1 ((11R)-8-chloro-3,11-dimethyl-2-(oxan-4-yl)-2,4,10,11,12,13-hexahydro-9,5-(azeno)pyrazolo[3,4-b][1,4,6,10]oxatriazacyclotridecine)

これはPDB形式変換不可エントリーです。
10HY の概要
エントリーDOI10.2210/pdb10hy/pdb
分子名称Serine/threonine-protein kinase Chk1, (11R)-8-chloro-3,11-dimethyl-2-(oxan-4-yl)-2,4,10,11,12,13-hexahydro-9,5-(azeno)pyrazolo[3,4-b][1,4,6,10]oxatriazacyclotridecine (3 entities in total)
機能のキーワードlrrk2, parkinson's, kinase, transferase-inhibitor complex, transferase/inhibitor
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計34473.06
構造登録者
Palte, R.L.,Yu, E.C.,Zhou, H. (登録日: 2026-01-21, 公開日: 2026-04-08)
主引用文献Yu, E.C.,Zhou, H.,Yan, X.,Logan, K.M.,Li, D.,Gulati, A.,Poremba, K.E.,Ardolino, M.J.,Su, J.,Xiao, D.,Palte, R.L.,McMinn, S.E.,Nogle, L.M.,Adpressa, D.A.,Burgess, S.A.,Xiong, T.,Otte, K.M.,Chobanian, H.R.,Bass, A.,Lee, S.,Pearson, K.,Messina, E.,Parisi, M.,Barnum, J.,Sobol, Z.,Ciaccio, P.J.,DiMauro, E.F.,Fell, M.J.,Fuller, P.H.
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease.
J.Med.Chem., 2026
Cited by
PubMed Abstract: Genetic mutations in the leucine-rich repeat kinase 2 (LRRK2) protein have been linked to Parkinson's disease (PD), a disabling and progressive neurodegenerative disorder for which treatments are limited. Herein, we describe the invention of a macrocyclic LRRK2 inhibitor lead chemical series. Rigorous application of knowledge-, structure-, and property-based drug design culminated in the discovery of compound , which was profiled extensively before it was determined to be clastogenic, which halted its progression. Parallel optimization of kinome selectivity and PXR activation through structure- and property-based drug design resulted in the discovery of the lead macrocycle compound . This macrocycle boasts a remarkably low projected human QD dose, is nongenotoxic, and achieved encouraging brain penetration in early preclinical models.
PubMed: 41906303
DOI: 10.1021/acs.jmedchem.6c00238
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.03 Å)
構造検証レポート
Validation report summary of 10hy
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon